Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial
Journal article, 2017
management
insulin sensitivity
metaanalysis
lipid profile
insulin-resistance
glucose-homeostasis
gut microbiota
obesity
probiotics
secretion
bile acids
gut microbiota
probiotic
controlled clinical-trial
Lactobacillus reuteri DSM 17938
Author
Reza Mobini
University of Gothenburg
Valentina Tremaroli
University of Gothenburg
Marcus Ståhlman
University of Gothenburg
Fredrik Karlsson
Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology
Max Levin
University of Gothenburg
M. Ljungberg
University of Gothenburg
M. Sohlin
University of Gothenburg
H. B. Forslund
University of Gothenburg
Rosie Perkins
University of Gothenburg
Fredrik Bäckhed
University of Copenhagen
University of Gothenburg
P. A. Jansson
University of Gothenburg
Diabetes, Obesity and Metabolism
1462-8902 (ISSN) 1463-1326 (eISSN)
Vol. 19 4 579-589Subject Categories
Endocrinology and Diabetes
Other Clinical Medicine
Nutrition and Dietetics
DOI
10.1111/dom.12861
PubMed
28009106